Median survival:Control/IRE/DC vaccine: 35/44/49 days.IRE + anti-PD-1: 77 days. Twice as high mean number of tumor-infiltrating CD8+ T cells compared to IRE alone. This evidence concerns the gene CD8A and neoplasm.